Escala pronóstica de Glasgow como predictor de mortalidad en pacientes oncológicos críticos

Q4 Medicine Medicina Clinica Practica Pub Date : 2023-10-01 DOI:10.1016/j.mcpsp.2023.100395

Melissa Lorena Vasquez-Cabrera , Gustavo Adolfo Vásquez-Tirado , María del Carmen Cuadra-Campos , Claudia Vanessa Quispe-Castañeda , Edinson Dante Meregildo-Rodríguez

{"title":"Escala pronóstica de Glasgow como predictor de mortalidad en pacientes oncológicos críticos","authors":"Melissa Lorena Vasquez-Cabrera , Gustavo Adolfo Vásquez-Tirado , María del Carmen Cuadra-Campos , Claudia Vanessa Quispe-Castañeda , Edinson Dante Meregildo-Rodríguez","doi":"10.1016/j.mcpsp.2023.100395","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To determine if the Glasgow Prognostic Scale (EPG) is a predictor of mortality in critically ill cancer patients at the Instituto Especializado en Enfermedades Neoplásicas (IREN), Trujillo, Peru during 2022.</p></div><div><h3>Material and methods</h3><p>A cohort study was carried out. retrospective with 191 patients who were admitted to the Intensive Care Unit (ICU) of IREN, Trujillo, Peru during the previous 3 years. Clinical and laboratory variables, EPG and their association with mortality were evaluated through chi2, T-Student and multivariate analysis with binomial logistic regression.</p></div><div><h3>Results</h3><p>Of the 191 patients included in the study, 100 died (52.4%), with a mean age of 62.7 years and 51% were female. The variables that were associated with mortality in the multivariate analysis were BMI, days spent in the ICU, hemoglobin, and LDH.</p></div><div><h3>Conclusions</h3><p>The LDH component of the EPG is associated with mortality in critical cancer patients. In addition, they are variables associated with mortality, BMI, days of stay in the ICU, hemoglobin.</p></div>","PeriodicalId":36921,"journal":{"name":"Medicina Clinica Practica","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina Clinica Practica","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2603924923000332","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Objective

To determine if the Glasgow Prognostic Scale (EPG) is a predictor of mortality in critically ill cancer patients at the Instituto Especializado en Enfermedades Neoplásicas (IREN), Trujillo, Peru during 2022.

Material and methods

A cohort study was carried out. retrospective with 191 patients who were admitted to the Intensive Care Unit (ICU) of IREN, Trujillo, Peru during the previous 3 years. Clinical and laboratory variables, EPG and their association with mortality were evaluated through chi2, T-Student and multivariate analysis with binomial logistic regression.

Results

Of the 191 patients included in the study, 100 died (52.4%), with a mean age of 62.7 years and 51% were female. The variables that were associated with mortality in the multivariate analysis were BMI, days spent in the ICU, hemoglobin, and LDH.

Conclusions

The LDH component of the EPG is associated with mortality in critical cancer patients. In addition, they are variables associated with mortality, BMI, days of stay in the ICU, hemoglobin.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

格拉斯哥预后量表作为危重肿瘤患者死亡率的预测指标

目的确定格拉斯哥预后量表（EPG）是否是秘鲁特鲁希略新公共卫生研究所（IREN）2022年癌症危重患者死亡率的预测指标。材料和方法进行了一项队列研究。回顾性分析了过去3年中入住秘鲁特鲁希略IREN重症监护室（ICU）的191名患者。临床和实验室变量、EPG及其与死亡率的关系通过chi2、T-Student和二项逻辑回归的多变量分析进行评估。结果191例患者中，100例死亡（52.4%），平均年龄62.7岁，51%为女性。在多变量分析中，与死亡率相关的变量是BMI、在ICU的天数、血红蛋白和LDH。结论EPG的LDH成分与癌症危重患者的死亡率有关。此外，它们也是与死亡率、BMI、ICU住院天数、血红蛋白相关的变量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊